Xencor Inc (XNCR)

Exchange
NASDAQ
Symbol
XNCR
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients and autoimmune diseases in the United States and internationally. The company is headquartered in Monrovia, California.
Country
USA

Stock price

At close: November 20, 2024

  • Open
    23.62
  • High
    23.76
  • Low
    23.22
  • Close
    23.72
  • Volume
    546,630

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
13.76
Payables turnover
4.56
Working capital turnover
0.35
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
26.53
Number of days of payables
80.00
Fixed asset turnover
2.83
Total asset turnover
0.20
 Liquidity ratios
Current ratio
7.36
Quick ratio
7.17
Cash ratio
7.01
Cash conversion cycle
-53.47
 Solvency ratios
Debt-to-assets ratio
0.02
Debt-to-capital ratio
0.02
Debt-to-equity ratio
0.02
Financial leverage ratio
1.42
Interest coverage
-47.53
 Profitability ratios
Gross profit margin
66.04%
Operating profit margin
-74.16%
Pretax margin
-64.34%
Net profit margin
-67.45%
Operating return on assets (Operating ROA)
-14.55%
Return on assets (ROA)
-13.23%
Return on total capital
-20.29%
Return on equity (ROE)
-18.85%